Table 2.
Characteristics of patients who received comprehensive medication management in the post-PCT period across the different service bundles
| Characteristic | SB1 (n=7) |
SB2 (n=49) |
SB3 (n=649) |
SB4 (n=119) |
SB5 (n=56) |
|---|---|---|---|---|---|
| Sex n (%) | |||||
| Female | 3 (42.9%) | 23 (46.9%) | 354 (54.6%) | 61 (51.3%) | 36 (64.3%) |
| Age n (%) | |||||
| 18-34 | 2 (28.6%) | 8 (16.3%) | 22 (3.4%) | 6 (5.0%) | 5 (8.9%) |
| 35-50 | 0 (0%) | 8 (16.3%) | 82 (12.6%) | 29 (24.4%) | 4 (7.1%) |
| 51-65 | 3 (42.9%) | 24 (49.0%) | 215 (33.1%) | 48 (40.3%) | 18 (32.1%) |
| 65+ | 2 (28.6%) | 9 (18.4%) | 330 (50.8%) | 36 (30.3%) | 29 (51.8%) |
| Race n (%) | |||||
| White | 3 (42.9%) | 36 (73.5%) | 518 (79.8%) | 99 (83.2%) | 48 (85.7%) |
| Black or African American | 2 (28.6%) | 5 (10.2%) | 57 (8.8%) | 11 (9.2%) | 3 (5.4%) |
| Asian | 2 (28.6%) | 2 (4.1%) | 41 (6.3%) | 7 (5.9%) | 2 (3.6%) |
| Other | 0 (0%) | 0 (0%) | 6 (0.9%) | 2 (1.7%) | 2 (3.6%) |
| Unknown | 0 (0%) | 6 (12.2%) | 27 (4.2%) | 0 (0%) | 1 (1.8%) |
| Mean number of conditions (SD) | 12.1 (14.8) | 8.4 (5.6) | 18.8 (11.1) | 12.4 (8.7) | 34 (12.1) |
| Specific Elixhauser Conditions | |||||
| Diabetes | 2 (28.6%) | 13 (26.5%) | 172 (26.5%) | 41 (34.5%) | 10 (17.9%) |
| Hypertension | 2 (28.6%) | 15 (30.6%) | 171 (26.3%) | 31 (26.05%) | 15 (26.8%) |
| Chronic pulmonary disease | 1 (14.3%) | 10 (20.4%) | 150 (23.1%) | 25 (21.0%) | 10 (17.9%) |
| Depression | 3 (42.9%) | 12 (24.5%) | 161 (24.8%) | 28 (23.5%) | 10 (17.9%) |
| Obesity | 4 (57.1%) | 21 (42.9%) | 232 (35.7%) | 45 (37.8%) | 21 (37.5%) |
| Mean number of medications (SD) | 9.4 (9) | 7.1 (4.37) | 14.6 (7.65) | 11.3 (6.5) | 23.3 (10.18) |
| Number of in-person PCP visits n (%) | |||||
| 0 | 5 (71.4%) | 12 (24.5%) | 182 (28.0%) | 38 (31.9%) | 0 (0%) |
| 1 | 1 (14.3%) | 18 (36.7%) | 85 (13.1%) | 21 (17.6%) | 1 (1.8%) |
| 2 | 0 (0%) | 13 (26.5%) | 127 (19.6%) | 24 (20.2%) | 4 (7.1%) |
| 3 | 0 (0%) | 4 (8.2%) | 87 (13.4%) | 14 (11.8%) | 13 (23.2%) |
| 4+ | 1 (14.3%) | 2 (4.1%) | 168 (25.9%) | 22 (18.5%) | 38 (67.9%) |
| Mean count of hospitalizations (SD) | 0.7 (1.5) | 0.1 (0.32) | 0.4 (1.09) | 0.1 (0.25) | 0.8 (1.1) |
| Mean count of ED visits (SD) | 0.6 (0.79) | 0.1 (0.44) | 0.5 (1.31) | 0.2 (0.62) | 1.1 (1.67) |
| Number of CMM visits n (%) | |||||
| 1 | 2 (28.6%) | 22 (44.9%) | 261 (40.2%) | 44 (37.0%) | 13 (23.1%) |
| 2 | 1 (14.3%) | 19 (38.8%) | 165 (25.4%) | 31 (26.1%) | 8 (14.3%) |
| 3 | 3 (42.9%) | 6 (12.2%) | 90 (13.9%) | 15 (12.6%) | 13 (23.2%) |
| 4+ | 1 (14.3%) | 2 (4.1%) | 133 (20.5%) | 29 (24.4%) | 22 (39.3%) |
| Mean number of MTPs identified (SD) | 2 (1.83) | 1.8 (1.16) | 2.8 (1.74) | 2.4 (1.75) | 4 (1.49) |
| MTP Classification n (%) | |||||
| Indication | |||||
| Unnecessary Drug Therapy | 1 (14.3%) | 6 (12.2%) | 164 (25.3%) | 24 (20.2%) | 21 (37.5%) |
| Needs additional therapy | 3 (42.9%) | 29 (59.2%) | 441 (68.0%) | 80 (67.2%) | 52 (92.9%) |
| Effectiveness | |||||
| Different Drug Needed | 0 (0%) | 7 (14.3%) | 157 (24.2%) | 30 (25.2%) | 21 (37.5%) |
| Dose too low | 3 (42.9%) | 19 (38.8%) | 334 (51.4%) | 57 (47.9%) | 38 (67.9%) |
| Safety | |||||
| Adverse drug reaction | 2 (28.6%) | 11 (22.4%) | 240 (37.0%) | 36 (30.3%) | 31 (55.4%) |
| Dose too high | 1 (14.3%) | 11 (22.4%) | 198 (30.5%) | 25 (21.0%) | 33 (58.9%) |
| Adherence | 2 (28.6%) | 15 (30.6%) | 260 (40.1%) | 34 (28.6%) | 35 (62.5%) |
SB service bundle, PCP primary care provider, ED emergency department, CMM comprehensive medication management, MTP medication therapy problem